Currently Recruiting Studies

Let’s Stop Lyme Disease in its Tracks! Join our study to help people suffering from Lyme. Our study aims to discover new ways to diagnose and better treat people that experience a wide range of symptoms after being infected with Lyme and COVID. Recruiting Volunteers: Healthy, Acute Lyme, Chronic Lyme, Long COVID.

The Biomechatronics Group at the MIT Media Lab is looking for UPPER LIMB AMPUTEES interested in being part of an advanced prosthesis study. For questions, please contact mariarg [at] mit.edu (Maria Ramos Gonzalez, PhD) or mfernan [at] media.mit.edu (Michael Fernandez).

This is an MRI study comparing the brain physiology of people with Long COVID with healthy participants. It involves a 2-3 hour visit at the Martinos Center (149 13th Street, Charlestown, MA 02129) that includes filling out questionnaires and participating in an MRI scan. Participants will receive $100 for completion of the study. Sign up here to participate.

The Bridge2AI Mood Disorder Study is investigating how voice can be used as a biomarker for detecting and diagnosing mood disorders/mental health conditions, such as depression, bipolar disorder and schizophrenia. The study will take place in-person at MIT, take around an hour to complete, and participants will be compensated $50.00 for their time. 

The MIT Media Lab Affective Computing group is looking for 50 healthy adults to participate in a study of links between sleep, circadian rhythm, and well-being. Participants will wear a smartwatch for 14 days, respond to surveys, and take an at-home dim-light melatonin onset (DLMO) saliva test. Participants must be 18-60 years old, use an Android phone, and reside in Greater Boston. You will receive $195 by check upon completion. Sign up to participate here.

Immersion Lab is looking for participants for its study "Immersive athlete-training technology and data-driven coaching support in fencing."

An MIT-led team is developing a device that could be a more comfortable treatment option for OSA patients and seeks volunteers for a small research study.

Researchers across the United States are seeking volunteers with migraine, ages 18-70, to participate in a research study comparing the effectiveness of the medications atogepant (Qulipta) vs. propranolol (Inderal) vs. topiramate (Topamax).

You may be eligible to participate if:
1. You have migraine with or without Aura
2. You have at least 4 moderate to severe headaches a month
3. You have never taken these three medications before
4. You are willing to be randomly assigned to one of these medications

Participation will last for 16 weeks, with a possibility of up to 52 weeks, and includes 5-7 study visits (some in person in Hyde Park and some virtual). You will be asked to complete a headache diary and answer questionnaires.

You will receive $50 for each completed research visit, and $50 for each month during which you provide headache diary data on at least 80% of the days, up to a total of 4 months. If you complete the entire study, you will receive up to $550.

1. Population of interest- American students who have graduated from an American International or intercultural high school and who had enrolled in first term, first year at an American international or global focused university
2. Length of study visits - under 20 minutes to complete Digital Demographic Survey; up to 60 minutes for Virtual Interview
3. Location of study visits- virtual
4. Very brief summary of visit- Visit #1 - Participant will complete a Digital Demographic Survey remotely; Visit #2- Participant in a private setting of their choosing will perform Virtual Interview with PI remotely
5. Compensation - none

We are seeking perimenopausal women (ages 40-55) to participate in a 14-30 day observational study examining the relationship between hormone levels, wearable biometric signals, and symptoms like hot flashes, sleep disruption, and mood changes. The study involves one in-person visit at the MIT Center for Clinical and Translational Research (CCTR) for consent and device setup, with all remaining data collection done remotely from home. Participants will wear a sensor device, complete three daily urine-based hormone tests, and fill out a brief daily symptom survey via a secure online platform. Participants will receive $95 upon completion.